PCSK9 inhibitors: role in reducing cardiovascular diseases | Malyarevskaya | South Russian Journal of Therapeutic Practice

South Russian Journal of Therapeutic Practice

ISSN 2712-8156 (Print)

eng | рус

Preview

South Russian Journal of Therapeutic Practice

Advanced search

Archives

Download this PDF file

For citations:

Malyarevskaya O.V., Namitokov A.M., Kruchinova S.V., Kosmacheva E.D. PCSK9 inhibitors: role in reducing cardiovascular diseases. South Russian Journal of Therapeutic Practice. 2022;3(2):32-40. (In Russ.) https://doi.org/10.21886/2712-8156-2022-3-2-32-40

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2712-8156 (Print)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Chesnikova Anna I.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

O. V. Malyarevskaya
S. V. Ochapovsky Scientific institution – Regional Clinical Hospital № 1
Russian Federation

Olga V. Malyarevskaya, cardiologist of the Department of Emergency Cardiology № 1

Krasnodar

A. M. Namitokov
S. V. Ochapovsky Scientific institution – Regional Clinical Hospital № 1
Russian Federation

Alim M. Namitokov, PhD, Head of the Department of Emergency Cardiology № 2

Krasnodar

S. V. Kruchinova
S. V. Ochapovsky Scientific institution – Regional Clinical Hospital № 1
Russian Federation

Sofia V. Kruchinova, cardiologist of the Department of Emergency Cardiology № 1

Krasnodar

E. D. Kosmacheva
S. V. Ochapovsky Scientific institution – Regional Clinical Hospital № 1
Russian Federation

Elena D. Kosmacheva, M.D, Deputy Chief Physician for Medical Care

Krasnodar

Notifications